Bioconversion of Tetracycline Antibiotics to Novel Glucoside Derivatives by Single-Vessel Multienzymatic Glycosylation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The single-vessel multienzyme UDP-α-D-glucose recycling system was coupled with a forward glucosylation reaction to produce novel glucose moiety-conjugated derivatives of different tetracycline antibiotic analogs. Among five tetracycline analogs used for the reaction, four molecules (chlorotetracycline, doxytetracycline, meclotetracycline, and minotetracycline) were accepted by a glycosyltransferase enzyme, YjiC, from Bacillus licheniformis to produce glucoside derivatives. However, the enzyme was unable to conjugate sugar units to rolitetracycline. All glucosides of tetracycline derivatives were characterized by ultraviolet absorbance maxima, ultra-pressure liquid chromatography coupled with photodiode array, and high-resolution quadruple time-of-flight electrospray mass spectrometry analyses. These synthesized glucosides are novel tetracycline derivatives.
Abstract
The single-vessel multienzyme UDP-α-D-glucose recycling system was coupled with a forward glucosylation reaction to produce novel glucose moiety-conjugated derivatives of different tetracycline antibiotic analogs. Among five tetracycline analogs used for the reaction, four molecules (chlorotetracycline, doxytetracycline, meclotetracycline, and minotetracycline) were accepted by a glycosyltransferase enzyme, YjiC, from Bacillus licheniformis to produce glucoside derivatives. However, the enzyme was unable to conjugate sugar units to rolitetracycline. All glucosides of tetracycline derivatives were characterized by ultraviolet absorbance maxima, ultra-pressure liquid chromatography coupled with photodiode array, and high-resolution quadruple time-of-flight electrospray mass spectrometry analyses. These synthesized glucosides are novel tetracycline derivatives.
참고문헌 (27)
- Chopra I, "Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance", Microbiol. Mol. Biol. Rev., 65, pp.232~260 (2001)
- Darken MA, "Production of tetracycline by Streptomyces aureofaciens in synthetic media", Appl. Microbiol., 8, pp.46~51 (1960)
- Testa RT, "In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines", Antimicrob. Agents Chemother., 37, pp.2270~2277 (1993)[DOI]
- Nelson ML, "Versatile and facile synthesis of diverse semisynthetic tetracycline derivatives via Pd-catalyzed reactions", J. Org. Chem., 68, pp.5838~5851 (2003)
- Liu F, "Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics", Curr. Opin. Chem. Biol., 32, pp.48~57 (2016)[DOI]
- Karami N, "Tetracycline resistance in Escherichia coli and persistence in the infantile colonic microbiota", Antimicrob. Agents Chemother., 50, pp.156~161 (2006)[DOI]
- Li W, "Mechanism of tetracycline resistance by ribosomal protection protein Tet(O)", Nat. Commun., 4, pp.1477~ (2013)[DOI]
- Pandey RP, "Microbial production of natural and non-natural flavonoids: pathway engineering, directed evolution and systems", synthetic biology, 2016, pp.34, 634~662
- Zhang J, "Synthesis and antibacterial activity of doxycycline neoglycosides", J. Nat. Prod., 76, pp.1627~1636 (2013)[DOI]
- Kim SJ, "Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus", J. Mol. Biol., 377, pp.281~293 (2008)
- Patti GJ, "Vancomycin and oritavancin have different modes of action in Enterococcus faecium", J. Mol. Biol., 392, pp.1178~1191 (2009)[DOI]
- Brade KD, "Oritavancin: a new lipoglycopeptide antibiotic in the treatment of gram-positive infections", Infect. Dis. Ther., 5, pp.1~15 (2016)[DOI]
- Marcone GL, "Glycopeptides: an old but up-to-date successful antibiotic class;Antimicrobials", pp.85~107 (2014), Springer-Verlag
- Lairson LL, "Glycosyltransferases: structures, functions, and mechanisms", Annu. Rev. Biochem., 77, pp.521~555 (2008)[DOI]
- Liang DM, "Glycosyltransferases: mechanisms and applications in natural product development", Chem. Soc. Rev., 44, pp.8350~8374 (2015)
- Elshahawi SI, "A comprehensive review of glycosylated bacterial natural products", Chem. Soc. Rev., 44, pp.7591~7697 (2015)
- Devasthale PV, "Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. III. Absolute stereochemistry of the dactylocyclines", J. Antibiot. (Tokyo), 45, pp.1907~1913 (1992)[DOI]
- Tymiak AA, "Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. II. Structure elucidation", J. Antibiot. (Tokyo), 45, pp.1899~1906 (1992)[DOI]
- Wells JS, "Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. I. Taxonomy, production, isolation and biological activity", J. Antibiot. (Tokyo), 45, pp.1892~1898 (1992)[DOI]
- Horiguchi T, "New naphthacenecarboxamide antibiotics, TAN-1518 A and B, have inhibitory activity against mammalian DNA topoisomerase I", J. Antibiot. (Tokyo), 47, pp.545~556 (1994)[DOI]
- Pickens LB, "Biochemical analysis of the biosynthetic pathway of an anticancer tetracycline SF2575", J. Am. Chem. Soc., 131, pp.17677~17689 (2009)[DOI]
- Chu LL, "Synthetic analog of anticancer drug daunorubicin from daunorubicinone using one-pot enzymatic UDP-recycling glycosylation", J. Mol. Catal. B Enzym., 124, pp.1~10 (2016)
- Pandey RP, "Assessing acceptor substrate promiscuity of YjiC-mediated glycosylation toward flavonoids", Carbohydr. Res., 393, pp.26~31 (2014)[DOI]
- Pandey RP, "Enzymatic synthesis of novel phloretin glucosides", Appl. Environ. Microbiol., 79, pp.3516~3521 (2013)[DOI]
- Parajuli P, "Enzymatic synthesis of epothilone A glycosides", AMB Express, 4, pp.31~ (2014)[DOI]
- Parajuli P, "Enzymatic glycosylation of the topical antibiotic mupirocin", Glycoconj. J., 31, pp.563~572 (2014)[DOI]
- Pandey RP, "Enzymatic biosynthesis of novel resveratrol glucoside and glycoside derivatives", Appl. Environ. Microbiol., 80, pp.7235~7243 (2014)[DOI]